VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up

Published on 31 Jan 2025 on Zacks · via Yahoo Finance

Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its oral, non-opioid,...

Read the rest of the article

Start tracking your investments with Statfolio

Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its oral, non-opioid...

Zacks · via Yahoo Finance 31 Jan 2025

The simplest way to invest in stocks is to buy exchange traded funds. But you can do a lot better...

Simply Wall St. · via Yahoo Finance 30 Jan 2025

The drug, Journavx™ (suzetrigine), represents the first new class of pain management medicine to ...

Technology Networks 30 Jan 2025

Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals'...

Investing.com 30 Jan 2025

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we a...

Insider Monkey · via Yahoo Finance 30 Jan 2025

Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...

Zacks · via Yahoo Finance 28 Jan 2025

The United States market has shown robust performance recently, climbing 3.0% in the last week an...

Simply Wall St. · via Yahoo Finance 24 Jan 2025

The stock of Vertex Pharmaceuticals Incorporated VRTX has declined almost 13% in the past six...

Zacks · via Yahoo Finance 23 Jan 2025

Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc....

Zacks · via Yahoo Finance 23 Jan 2025

Vertex Pharmaceuticals' SWOT analysis: stock outlook amid pipeline progress

Investing.com 21 Jan 2025